Non Small-cell Lung Cancer
7
0
0
5
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
13 treatments under study, led by Sunitinib
Research Leaders
10 sponsors active, led by Rennes University Hospital
Related Conditions
Often studied with 5 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 7 trials
100.0%
+13.4% vs benchmark
29%
2 trials in Phase 3/4
20%
1 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 5 completed trials
Clinical Trials (7)
Expanded Access of Sotorasib
Chemotherapy/Radiotherapy Versus Concomitant Chemotherapy Followed by Radiotherapy in Stage IIIB Non-small Cell Lung Cancer
Liquid Biopsy for Early Non-small Lung Cancer Detection
Trial Involving Subjects Over 70 Years of Age With Non Small-cell Lung Cancer of Stage IV and Comparing a "Classical" Strategy of Treatment Allocation, With an"Optimized" Strategy Allocating the Same Treatments
CABozantinib in Non-Small Cell Lung Cancer (NSCLC) Patients With MET Deregulation
Clinicopathological Features of NSCLC Patients Associated With the Chromosome 2p (EML4-ALK)
Cytochrom p450 3A4 and 1A2 Phenotyping for the Individualization of Treatment With Sunitinib or Erlotinib in Cancer Patients
Research Network
Common Treatments
- Sunitinib1
- Liquid Biopsy For Aberrant Dna Methylation Analysis Healthy Volunteer1
- Docetaxel 40mg7m2 D18 21 28 Gemcitabine 1200mgm2 D18 21 28 Concomitant Docetaxel 20mgm2wcarboplatin Auc 2w Concomitant Rdt 2gyd1
- Liquid Biopsy For Aberrant Dna Methylation Analysis Known Lung Cancer For Surgical Resection1
- Midazolam1
Active Sponsors
- Rennes University Hospital1
- Markus Joerger1
- Fondazione Ricerca Traslazionale1
- Aventis Pharmaceuticals1
- University of Basel1
Top Investigators
Instituto de Cancerología
Cantonal Hospital of St. Gallen
University of Arizona
Hospital Ramon y Cajal (Madrid)
Germans Trias i Pujol Hospital
Related Conditions
- Gastrointestinal Stroma Tumor1
- Renalcell Cancer1
- Locally Advanced Unresectable Nsclc1
- Locally Advanced Metastatic Nsclc1
- Nonsmall Cell Lung Cancer1